HIV remains one of the world’s biggest health threats and while great strides have been made in HIV treatment, with people living with HIV on effective treatment able to live long and full lives, stigma remains a challenge. Fear of harsh judgement and discrimination associated with HIV can prevent many people from getting tested and diagnosed, as well as starting and staying on treatment. Find out how we are committed to changing that, by minimising the impact of HIV on people’s lives through treatment, prevention and ultimately cure: 🔗 https://gsk.to/3SkUn0g 👈 #AIDS2024
About us
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Website
-
http://www.gsk.com
External link for GSK
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Brentford, Middlesex
- Type
- Public Company
- Specialties
- Pharmaceutical products and Vaccines
Locations
Employees at GSK
Updates
-
HIV remains one of the world’s biggest health threats and while great strides have been made in HIV treatment, with people living with HIV on effective treatment able to live long and full lives, stigma remains a challenge.
This content isn’t available here
Access this content and more in the LinkedIn app
-
#News for #investors and #media: new data shared today at #AIDS2024 by our specialist HIV company, ViiV Healthcare, include updates from our pipeline that reinforce our leadership in HIV innovation and supporting the community. 🔗 Find out more: https://gsk.to/4cRI7MW
-
“There are three things necessary to ending the HIV/AIDS epidemic,” says Dr Nneka Nwokolo, Head of Global Patient Engagement for ViiV Healthcare, our specialist HIV company. “One is to test everybody so that you identify people living with HIV. Second is to treat people who you find have HIV. And third is to prevent HIV from occurring in people who don’t have it. You cannot end HIV without all of them, and prevention is key.” Find out what it means to change the course of disease through prevention 👇 #AIDS2024
-
#News for #Investors and #Media: Today, we announced that our marketing authorisation application for potential new indications for one of our #bloodcancer therapies, in combination with standards of care, has been accepted by the European Medicines Agency (EMA). Learn more: https://gsk.to/3W2QuOI
-
-
#Antimicrobialresistance is a global health issue that threatens millions of lives every year. In an interview with Bloomberg TV, our CEO, Emma Walmsley, and Chair of Fleming Initiative, Lord Darzi, discuss the urgent need to tackle #AMR through cross-sectoral partnership, innovative treatments and vaccines, and improved public awareness. Watch the interview: https://gsk.to/3W61omV
Why Drug-Resistant Superbugs Threaten Millions
https://www.youtube.com/
-
Het verschil maken door lokale organisaties te steunen? Dat is precies wat onze medewerkers deden op Together Day. Ze namen deel aan diverse sociale projecten 🌍 Inkendaal : https://www.inkendaal.be/ Pulderbos : https://lnkd.in/ep66Qmbf Kindervriend : https://lnkd.in/egjvwGuE Escalpade : https://escalpade.be/ Natuurtalent : https://lnkd.in/eTeKQiPj Croix Bleue : https://www.croixbleue.be/ Ferme de la Hulotte : https://lnkd.in/eXH858gd Bûûmplanters : https://buumplanters.be/ L’îlot : https://ilot.be/sil/ #GSK #TogetherDay #Volunteering
-
One-off climate shocks, ongoing conflicts and the emergence of serious public health concerns are putting increasing pressure on healthcare systems, particularly in lower-income countries. That’s why we’re committed to building resilience in healthcare systems, upskilling healthcare workers, supporting future African research leaders and creating sustainable long-term change to help people access the healthcare they need. Our approach is guided by local communities, experts and stakeholders, and we’re proud to partner with a number of amazing organisations to positively impact the health of the most vulnerable populations in sub-Saharan Africa, and beyond. Here’s a glimpse of what we’ve achieved with our partners between 2021-2023, and you can find out more in our Impact Partnerships report 👉 https://gsk.to/4cY7cW9 Save the Children UK I AMREF I mothers2mothers I Last Mile Health
-
#News for #investors and #media: ViiV Healthcare, our specialist HIV company, are presenting over 20 abstracts from our innovative pipeline and portfolio of medicines at #AIDS2024, as well as showcasing our commitment to the #HIV community. Find out more: https://www.gsk.com/en-gb/
-
🚢 Now shipped: Flu doses for this upcoming season have left the warehouse! July might not be when most of us start thinking about the flu, but in order to protect people from influenza, we’re working proactively to ensure a steady supply of vaccines to help protect people from this illness. As part of our commitment to preventative healthcare, we’re helping families everywhere stay ahead of the flu. 💪 Details: https://gsk.to/3WiiXRR #FluVaccine #StayAhead #FluIsAFamilyAffair